These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30718250)

  • 21. Ring stage dormancy of Plasmodium falciparum tolerant to artemisinin and its analogues - A genetically regulated "Sleeping Beauty".
    Auparakkitanon S; Wilairat P
    Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():61-64. PubMed ID: 36708651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.
    Loesbanluechai D; Kotanan N; de Cozar C; Kochakarn T; Ansbro MR; Chotivanich K; White NJ; Wilairat P; Lee MCS; Gamo FJ; Sanz LM; Chookajorn T; Kümpornsin K
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():16-22. PubMed ID: 30580023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin resistance phenotypes and K13 inheritance in a
    Sá JM; Kaslow SR; Krause MA; Melendez-Muniz VA; Salzman RE; Kite WA; Zhang M; Moraes Barros RR; Mu J; Han PK; Mershon JP; Figan CE; Caleon RL; Rahman RS; Gibson TJ; Amaratunga C; Nishiguchi EP; Breglio KF; Engels TM; Velmurugan S; Ricklefs S; Straimer J; Gnädig NF; Deng B; Liu A; Diouf A; Miura K; Tullo GS; Eastman RT; Chakravarty S; James ER; Udenze K; Li S; Sturdevant DE; Gwadz RW; Porcella SF; Long CA; Fidock DA; Thomas ML; Fay MP; Sim BKL; Hoffman SL; Adams JH; Fairhurst RM; Su XZ; Wellems TE
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12513-12518. PubMed ID: 30455312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and structure elucidation of a steroidal moiety from
    Pradhan D; Biswasroy P; Sahu DK; Ghosh G; Rath G
    J Biomol Struct Dyn; 2023 Jul; 41(11):4993-5006. PubMed ID: 35585777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016.
    Ikeda M; Kaneko M; Tachibana SI; Balikagala B; Sakurai-Yatsushiro M; Yatsushiro S; Takahashi N; Yamauchi M; Sekihara M; Hashimoto M; Katuro OT; Olia A; Obwoya PS; Auma MA; Anywar DA; Odongo-Aginya EI; Okello-Onen J; Hirai M; Ohashi J; Palacpac NMQ; Kataoka M; Tsuboi T; Kimura E; Horii T; Mita T
    Emerg Infect Dis; 2018 Apr; 24(4):718-726. PubMed ID: 29553316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
    Phompradit P; Chaijaroenkul W; Na-Bangchang K
    Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam.
    Manh ND; Thanh NV; Quang HH; Van NTT; San NN; Phong NC; Birrell GW; Edstein MD; Edgel KA; Martin NJ; Chavchich M
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0027621. PubMed ID: 34570647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
    de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
    Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from Central African Republic (2017-2019).
    Nzoumbou-Boko R; Panté-Wockama CG; Ngoagoni C; Petiot N; Legrand E; Vickos U; Gody JC; Manirakiza A; Ndoua C; Lombart JP; Ménard D
    Malar J; 2020 May; 19(1):191. PubMed ID: 32448203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016).
    Prosser C; Meyer W; Ellis J; Lee R
    PLoS One; 2018; 13(5):e0197369. PubMed ID: 29813085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K13 propeller domain mutations and pfmdr1 amplification in isolates of Plasmodium falciparum collected from Thai-Myanmar border area in 2006-2010.
    Phompradit P; Chaijaroenkul W; Muhamad P; Na-Bangchang K
    Folia Parasitol (Praha); 2019 May; 66():. PubMed ID: 31239407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
    Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates.
    Tirrell AR; Vendrely KM; Checkley LA; Davis SZ; McDew-White M; Cheeseman IH; Vaughan AM; Nosten FH; Anderson TJC; Ferdig MT
    Malar J; 2019 Aug; 18(1):295. PubMed ID: 31462253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of Artemisinin-Resistant Malaria in Africa.
    Balikagala B; Fukuda N; Ikeda M; Katuro OT; Tachibana SI; Yamauchi M; Opio W; Emoto S; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Mita T
    N Engl J Med; 2021 Sep; 385(13):1163-1171. PubMed ID: 34551228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.